Related Experiment Video
Updated: Apr 27, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population
Stephanie J Fox1, Miguel A Park1
1Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.
Insights
Penicillin skin testing is safe and effective for evaluating penicillin allergy in children. This study found no adverse reactions to the skin test itself, demonstrating its utility in pediatric allergy assessment.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Pharmacology
- Diagnostic Testing
Background:
- Penicillin skin testing is validated for adult penicillin allergy assessment.
- Commercial penicillin skin test reagents (e.g., Pre-Pen) are not FDA-approved for pediatric use.
- Limited data exists on the safety and validity of penicillin skin testing in children.
Purpose of the Study:
- To evaluate the safety and effectiveness of penicillin skin testing in children with a history of penicillin allergy.
- To compare the rate of positive penicillin skin tests in children versus adults.
Main Methods:
- Children under 18 with a history of penicillin allergy underwent penicillin skin testing.
- Demographics, skin test results, and subsequent reactions to penicillin or the skin test were recorded.
- Chi-squared test was used to compare positive skin test rates between pediatric and adult populations.
Main Results:
- Of 778 children tested, 8.5% had a positive skin test, and 1.1% had an equivocal result.
- Children were significantly more likely to have a positive penicillin skin test compared to adults (8.5% vs. 3.6%).
- No adverse reactions to the penicillin skin testing procedure were observed in any children.
Conclusions:
- Penicillin skin testing is a safe diagnostic tool for evaluating penicillin allergy in pediatric patients.
- The testing demonstrated effectiveness in identifying children with penicillin allergy.
- Findings support the expanded use of penicillin skin testing in the pediatric population.
Background:
Penicillin skin testing has been validated in the evaluation of adult patients with penicillin allergy. However, the commercially available benzylpenicilloyl polylysine (Pre-Pen) is not indicated in the pediatric population. Moreover, the safety and validity of penicillin skin testing in the pediatric population has not been well studied.
Objective:
We describe the safety and validity of penicillin skin testing in the evaluation of children with a history of penicillin allergy.
Methods:
Children (<18 years) with a history of penicillin allergy were evaluated with penicillin skin tests and were reviewed for basic demographics, penicillin skin test results, adverse drug reaction to penicillin after penicillin skin test, and adverse reaction to penicillin skin test. By using the χ(2) test, we compared the differences in the proportion of children and adults with a positive penicillin skin test. P value (<.05) was considered statistically significant. The institutional review board approved the study, and all the subjects signed written informed consents.
Results:
A total of 778 children underwent penicillin skin testing; 703 of 778 patients had a negative penicillin skin test (90.4%), 66 had a positive test (8.5%), and 9 had an equivocal test (1.1%). Children were more likely to have a positive penicillin skin test (P < .0001) compared with adults (64 of 1759 [3.6%]); 369 of 703 patients with negative penicillin skin test (52%) were challenged with penicillin, and 14 of 369 patients (3.8%) had an adverse drug reaction. No adverse reactions to penicillin skin testing were observed.
Conclusion:
Penicillin skin testing was safe and effective in the evaluation of children with a history of penicillin allergy.
More Related Videos
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
07:10Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
Related Concept Videos
Allergic Reactions: Anaphylaxis
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Allergic Reactions
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pneumonia III: Complications and Assessment